How is Lymphangiomatosis diagnosed?

TL;DR: Diagnosing Lymphangiomatosis is a complex process that relies on a combination of advanced diagnostic imaging, such as MRI or CT scans, and tissue biopsy to confirm the presence of abnormal lymphatic vessel proliferation. Because Lymphangiomatosis is a rare, systemic condition, it often requires a multidisciplinary team to confirm the diagnosis and distinguish it from other vascular anomalies.

How is Lymphangiomatosis diagnosed?

The diagnostic journey for Lymphangiomatosis is often prolonged, frequently spanning years as patients navigate a "diagnostic odyssey." Because the disease can affect multiple organ systems—including the bones, lungs, and spleen—initial symptoms are often misattributed to more common conditions. A definitive diagnosis of Lymphangiomatosis typically involves:

• Clinical Evaluation: A thorough physical exam and review of systemic symptoms.


• Imaging Studies: MRI (the gold standard for soft tissue) and CT scans are essential to map the distribution of lymphatic lesions.


• Biopsy: Histopathological examination of affected tissue is often required to confirm the presence of endothelial-lined channels characteristic of Lymphangiomatosis.


• Differential Diagnosis: Specialists must distinguish Lymphangiomatosis from Gorham-Stout disease (vanishing bone disease), lymphangioleiomyomatosis (LAM), and various forms of cystic angiomatosis.

Which specialists should be involved?

Given the multisystem nature of Lymphangiomatosis, patients should seek care from specialists in vascular anomalies, pediatric or adult hematology-oncology, or interventional radiology. Coordinating care through a center of excellence is vital, as general practitioners may lack familiarity with the rare clinical presentation of Lymphangiomatosis.

Why is early expert consultation important?

The frustration of receiving inconsistent information is a common experience for our 3 community members living with Lymphangiomatosis. Working with a specialist who understands the nuances of vascular malformations ensures that the correct diagnostic criteria are applied, which is critical for determining appropriate therapeutic pathways and avoiding unnecessary procedures.

Next steps

• Consult with a specialist in vascular anomalies or a tertiary research hospital.


• Request a referral to a multidisciplinary tumor board to review your imaging and biopsy results.


• Join the DiseaseMaps.org community to connect with others who have navigated the Lymphangiomatosis diagnostic process.


• Keep a comprehensive binder of all imaging reports and pathology slides to share with new specialists.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Portal for rare diseases and orphan drugs


• OMIM (Online Mendelian Inheritance in Man)


• International Society for the Study of Vascular Anomalies (ISSVA) classification guidelines